Cleared Traditional

K903364 - GERARD MEDICAL, INC. TRIM-PORT

K903364 is an FDA 510(k) clearance for GERARD MEDICAL, manufactured by Gerard Medical Enterprises, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 97-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1990
Decision
97d
Days
Class 2
Risk

K903364 is an FDA 510(k) clearance for the GERARD MEDICAL, INC. TRIM-PORT. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Gerard Medical Enterprises, Inc. (Brimfield, US). The FDA issued a Cleared decision on October 31, 1990 after a review of 97 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Gerard Medical Enterprises, Inc. devices

FDA 510(k) Submission Details - K903364

510(k) Number K903364 FDA.gov
FDA Decision Cleared Substantially Equivalent - Special 510(k) (SESK)
Date Received July 26, 1990
Decision Date October 31, 1990
Days to Decision 97 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 129d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 236
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K903364.
STRATO PLAST W/PRE-ATTACH CATH(LPS 6015)/MODIFIED
K905851 · Strato Medical Corp. · Apr 1991
STRATO STAND METAL PORTS (LPS 1013/1015)/MODIFIED
K905844 · Strato Medical Corp. · Apr 1991
VITAL-PORT(TM) M.R.I. VASCULAR ACCESS SYSTEM
K910005 · Med Institute, Inc. · Mar 1991
VITAL-PORT DUAL LUMEN VASCULAR ACCESS SYSTEM
K904077 · Med Institute, Inc. · Oct 1990
A-PORT IMPLANTABLE VASCULAR ACCESS SYSTEM LINE EX.
K903691 · Therex Corp. · Oct 1990
PORT-A-CATH IMPLANTABLE DRUG DELIVERY SYSTEM
K903220 · Pharmacia Deltec, Inc. · Oct 1990